Antengene unveils three pipeline programs at AACR 2026 as AnTenGager platform expands beyond UCB deal
Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
Read More Pharma Industry News XBiotech partners with BioBridge to develop plasma-based Covid-19 therapy US biopharmaceutical company XBiotech has partnered with BioBridge Global to develop potential plasma-based Covid-19 therapy using natural antibodies… bypharmanewsdailyApril 7, 2020
